Back HCV Treatment

Study Shows Treating Prisoners with Hepatitis C is Cost Effective

Chronic hepatitis C is common in U.S. prisons, with prevalence estimates ranging from about 10% to about 30%. A significant proportion of the HCV-infected population passes through the correctional system each year, providing a prime opportunity for diagnosis and treatment.

Read more: